Common severe infections in chronic granulomatous disease

Clinical Infectious Diseases

Volumn 60, Issue 8, 2015, Pages 1176-1183

  Marciano, Beatriz E ^a   Spalding, Christine ^a   Fitzgerald, Alan ^a   Mann, Daphne ^b   Brown, Thomas ^b   Osgood, Sharon ^a   Yockey, Lynne ^a   Darnell, Dirk N ^a   Barnhart, Lisa ^a   Daub, Janine ^a   Boris, Lisa ^b   Rump, Amy P ^b   Anderson, Victoria L ^a   Haney, Carissa ^a   Kuhns, Douglas B ^b   Rosenzweig, Sergio D ^c   Kelly, Corin ^d   Zelazny, Adrian ^c   Mason, Tamika ^a   Deravin, Suk See ^d   Kang, Elizabeth ^d   Gallin, John I ^d   Malech, Harry L ^c   Olivier, Kenneth N ^a   Uzel, Gulbu ^a   Freeman, Alexandra F ^a   Heller, Theo ^e   Zerbe, Christa S ^a   Holland, Steven M ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

bacterial infection; CGD; fungal infection; superoxide production; survival

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; GAMMA INTERFERON; ITRACONAZOLE; POSACONAZOLE; SUPEROXIDE; VORICONAZOLE;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BACTERIAL INFECTION; BURKHOLDERIA; BURKHOLDERIA INFECTION; CANDIDA; CAUSE OF DEATH; CHILD; CHRONIC GRANULOMATOUS DISEASE; GENOTYPE; HUMAN; LIVER ABSCESS; LUNG INFECTION; LYMPHADENITIS; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MYCOSIS; NEOSARTORYA; NOCARDIA; NOCARDIOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SERRATIA; SERRATIA INFECTION; SERRATIA MARCESCENS; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; BACTERIAL INFECTIONS; COHORT ANALYSIS; COMPLICATION; FEMALE; MALE; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL; YOUNG ADULT;

ADOLESCENT; ADULT; ASPERGILLOSIS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84926628040     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu1154     Document Type: Article

References (35)

1. Matute JD, Arias AA, Wright NA, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009; 114:3309-15.
2. Roos D, Kuhns DB, Maddalena A, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis 2010; 45:246-65.
3. Roos D, Kuhns DB, Maddalena A, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis 2010; 44:291-9.
4. Wolach B, Gavrieli R, de Boer M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol 2008; 129:103-14.
5. Fattahi F, Badalzadeh M, Sedighipour L, et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol 2011; 31:792-801.
6. Janeway CA, Craig J, Davidson M, Doroney W, Gitlin D, Sullivan JC. Hypergammaglobulinemia associated with severe recurrent and chronic nonspecific infections. AMA Am J Dis Child 1954; 388.
7. Quie PG. Chronic granulomatous disease of childhood. Adv Pediatr 1969; 16:287-300.
8. Bassiri-Jahromi S, Doostkam A. Fungal infection and increased mortality in patients with chronic granulomatous disease. J Mycol Med 2012; 22:52-7.
9. Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am 2013; 27:89-99, viii.
10. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363:2600-10.
11. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
12. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155-69.
13. van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: the European experience. PLoS One 2009; 4:e5234.
14. Freeman AF, Holland SM. Antimicrobial prophylaxis for primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2009; 9:525-30.
15. Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003; 348:2416-22.
16. Kang EM, Marciano BE, DeRavin S, Zarember KA, Holland SM, Malech HL. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol 2011; 127:1319-26; quiz 1327-8.
17. Marciano BE, Wesley R, De Carlo ES, et al. Long-Term interferongamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004; 39:692-9.
18. Guide SV, Stock F, Gill VJ, et al. Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J Infect Dis 2003; 187:845-53.
19. Beaute J, Obenga G, Le Mignot L, et al. Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France. Pediatr Infect Dis J 2011; 30:57-62.
20. Dorman SE, Gill VJ, Gallin JI, Holland SM. Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin Infect Dis 1998; 26:889-94.
21. Segal BH, Romani LR. Invasive aspergillosis in chronic granulomatous disease. Med Mycol 2009; 47(suppl 1):S282-90.
22. Antachopoulos C. Invasive fungal infections in congenital immunodeficiencies. Clin Microbiol Infect 2010; 16:1335-42.
23. Blumental S, Mouy R, Mahlaoui N, et al. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis 2011; 53:e159-69.
24. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989; 114(4 pt 1):555-60.
25. Jones LB, McGrogan P, Flood TJ, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol 2008; 152:211-8.
26. Kepenekli E, Soysal A, Kuzdan C, Ermerak NO, Yuksel M, Bak RM. Refractory invasive aspergillosis controlled with posaconazole and pulmonary surgery in a patient with chronic granulomatous disease: case report. Ital J Pediatr 2014; 40:2.
27. Rosen-Wolff A, Koch A, Friedrich W, Hahn G, Gahr M, Roesler J. Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease. Pediatr Infect Dis J 2004; 23:584-6.
28. Welzen ME, Bruggemann RJ, Van Den Berg JM, et al. A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease. Pediatr Infect Dis J 2011; 30:794-7.
29. Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 2005; 40:1684-8.
30. Feld JJ, Hussain N, Wright EC, et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008; 134:1917-26.
31. Disease TICG, Group. CS. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med 1991; 324:509-16.
32. Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 1990; 162:723-6.
33. Falcone EL, Holland SM. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management. Curr Opin Infect Dis 2012; 25:658-69.
34. Greenberg DE, Goldberg JB, Stock F, Murray PR, Holland SM, Lipuma JJ. Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center. Clin Infect Dis 2009; 48:1577-9.
35. Leiding JW, Marciano BE, Zerbe CS, Deravin SS, Malech HL, Holland SM. Diabetes, renal and cardiovascular disease in p47 phox-/-chronic granulomatous disease. J Clin Immunol 2013; 33:725-30.